Showing 3 of 3 recruiting trials for “Plasmablastic lymphoma”
RecruitingNCT06781359 ↗
Study on Plasmablastic Lymphoma Patients
👨⚕️ Alessia Castellino, MD, UO Ematologia, AO Santa Croce e Carle, Cuneo - Italy📍 23 sites📅 Started Feb 2025View details ↗
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
👨⚕️ Andrés Ferreri, Dr., Unità Linfomi - Dipartimento Oncoematologia -Istituto Scientifico San Raffaele - Milano📍 18 sites📅 Started Jul 2022View details ↗
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
👨⚕️ Ariela Noy, MD, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started May 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →